Antimullerian hormone (AMH) and age as predictors of preimplantation genetic testing for aneuploidies (PGT-A) cycle outcomes and blastocyst quality on day 5 in women undergoing in vitro fertilization (IVF)

被引:4
|
作者
Arnanz, A. [1 ,2 ,3 ,4 ]
Bayram, A. [1 ,2 ]
Elkhatib, I. [1 ,2 ]
Abdala, A. [1 ,2 ]
El-Damen, A. [1 ,2 ]
Patel, R. [1 ,2 ]
Lawrenz, B. [1 ,2 ,5 ]
Melado, L. [1 ,2 ]
Fatemi, H. [1 ,2 ]
De Munck, N. [6 ]
机构
[1] ART Fertil Clin Abu Dhabi & Dubai, Embryol Lab, Dubai, U Arab Emirates
[2] IVF Clin, Dubai, U Arab Emirates
[3] Univ Alcala de Henares, Biomed & Biotechnol Dept, Madrid, Spain
[4] IVIRMA, Embryol Lab, Madrid, Spain
[5] Womens Univ Hosp Tuebingen, Obstetr Dept, Tubingen, Germany
[6] UZ Brussels, Jette, Belgium
关键词
PGT-A; AMH; Age; Euploid rate; Blastocyst quality; ANTI-MULLERIAN HORMONE; CONTROLLED OVARIAN STIMULATION; ANTRAL FOLLICLE COUNT; EMBRYO QUALITY; OOCYTE QUALITY; MLLERIAN HORMONE; SERUM-LEVELS; MARKER; RESERVE; PREGNANCY;
D O I
10.1007/s10815-023-02805-z
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Purpose The objective of this study was to investigate whether women with diminished ovarian reserve who planned for PGT-A exhibit a lower number of blastocysts for biopsy, ploidy outcomes, and blastocyst quality on day 5, regardless of age. Methods A retrospective analysis was performed between March 2017 and July 2020 at ART Fertility Clinics Abu Dhabi, including couples that were triggered for final oocyte maturation in an ovarian stimulated cycle planned for PGT-A. Patients were stratified into four AMH groups: < 0.65 ng/ml, 0.65-1.29 ng/ml, 1.3-6.25 ng/ml, and > 6.25 ng/ml; four age categories: <= 30, 31-35, 36-40, and > 40 years. Main results and the role of chance A total of 1410 couples with a mean maternal age of 35.2 +/- 6.4 years and AMH of 2.7 +/- 2.6 ng/ml were included. In a multivariate logistic regression analysis, controlling for age, the chance of having at least one blastocyst biopsied/stimulated cycle (1156/1410), the chance of having at least one euploid blastocyst/stimulated cycle (880/1410), and the chance of having one euploid blastocyst once biopsy was performed (880/1156) were affected in all patients with AMH < 0.65 ng/ml [AdjOR 0.18[0.11-0.31] p = 0.008)], [AdjOR 0.18 [0.11-0.29] p < 0.001], and [AdjOR 0.34 [0.19-0.61] p = 0.015] as well as in patients with AMH 0.65-1.29 ng/ml (AdjOR 0.52 [0.32-0.84] p < 0.001), (AdjOR 0.49 [0.33-0.72] p < 0.001), and (AdjOR 0.57 [0.36-0.90] p < 0.001), respectively. In a multivariate linear regression analysis, AMH values did not affect blastocyst quality (- 0.72 [- 1.03 to - 0.41] p < 0.001). Conclusion Irrespective of age, patients with diminished ovarian reserve (AMH < 1.3 ng/ml) have a lower chance of having at least one blastocyst biopsied and lower chance of having at least one euploid blastocyst per ovarian stimulated cycle. Blastocyst quality was not affected by AMH values.
引用
收藏
页码:1467 / 1477
页数:11
相关论文
共 29 条
  • [1] Antimüllerian hormone (AMH) and age as predictors of preimplantation genetic testing for aneuploidies (PGT-A) cycle outcomes and blastocyst quality on day 5 in women undergoing in vitro fertilization (IVF)
    A. Arnanz
    A. Bayram
    I. Elkhatib
    A. Abdala
    A. El-Damen
    R. Patel
    B. Lawrenz
    L. Melado
    H. Fatemi
    N. De Munck
    Journal of Assisted Reproduction and Genetics, 2023, 40 : 1467 - 1477
  • [2] Current Applications and Controversies in Preimplantation Genetic Testing for Aneuploidies (PGT-A) in In Vitro Fertilization
    Carmen Morales
    Reproductive Sciences, 2024, 31 : 66 - 80
  • [3] Current Applications and Controversies in Preimplantation Genetic Testing for Aneuploidies (PGT-A) in In Vitro Fertilization
    Morales, Carmen
    REPRODUCTIVE SCIENCES, 2024, 31 (01) : 66 - 80
  • [4] An overview of the current and emerging platforms for preimplantation genetic testing for aneuploidies (PGT-A) in in vitro fertilization programs
    Chen, Hsin-Fu
    Chen, Ming
    Ho, Hong-Nerng
    TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2020, 59 (04): : 489 - 495
  • [5] THE EFFECT OF OBESITY ON EUPLOIDY RATES IN WOMEN UNDERGOING IN VITRO FERTILIZATION (IVF) WITH PREIMPLANTATION GENETIC TESTING (PGT).
    Hallisey, Stephanie M.
    Makhijani, Reeva B.
    Thorne, Jeffrey
    Godiwala, Prachi N.
    Nulsen, John
    Benadiva, Claudio A.
    Grow, Daniel R.
    Engmann, Lawrence
    FERTILITY AND STERILITY, 2020, 114 (03) : E106 - E106
  • [6] VALUE OF PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY (PGT-A) IN THE CONTEXT OF IN VITRO FERTILIZATION (IVF) USING DONOR OOCYTES.
    Daneshmand, Said
    Richter, Kevin S.
    Gu, Rebecca
    Miller, Danielle
    Tober, Diane
    Lin, Michelle P.
    Rio, Jazmin Lara
    Agashe, Ruchi
    Deland, Josie Lynn
    Kokjohn, Shannon
    FERTILITY AND STERILITY, 2021, 116 (03) : E401 - E401
  • [7] Frozen Blastocyst Transfer Cycle Following In Vitro Fertilization (IVF) with Pre-Implantation Genetic Testing for Aneuploidy (PGT-A) - Earlier is Better.
    Silberman, Jason
    Stewart, Joshua
    Chung, Pak
    Reichman, David
    Rosenwaks, Zev
    REPRODUCTIVE SCIENCES, 2020, 27 (SUPPL 1) : 185A - 185A
  • [8] TRIGGER DAY FOLLICLE-STIMULATING HORMONE (FSH) "BOOST'' INCREASES COSTS BUT DOES NOT IMPROVE OUTCOMES IN PATIENTS UNDERGOING IVF WITH PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY (PGT-A).
    Chamani, Isaac J.
    McCulloh, David H.
    Licciardi, Frederick L.
    FERTILITY AND STERILITY, 2019, 112 (03) : E193 - E194
  • [9] THE EFFECT OF PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY (PGT-A) ON IN VITRO FERTILIZATION (IVF) OUTCOMES WITH DONOR OOCYTES AND UTILIZATION OF ELECTIVE SINGLE EMBRYO TRANSFER (ESET)
    Miller, C.
    Broussard, A.
    Adaniya, G.
    Will, M.
    FERTILITY AND STERILITY, 2018, 109 (03) : E38 - E39
  • [10] Effect of accessibility of a genetic counselor on uptake of preimplantation genetic testing for aneuploidy (PGT-A) and carrier screening for patients undergoing in vitro fertilization
    Singh, Prapti
    Martin, Caitlin E.
    Jamro-Comer, Erica
    Andrews, Marisa V.
    Almgren-Bell, Alison
    Riley, Joan
    Jimenez, Patricia T.
    JOURNAL OF GENETIC COUNSELING, 2023, : 906 - 915